Supplementary Table 1 from HIST1H2BB and MAGI2 Methylation and Somatic Mutations as Precision Medicine Biomarkers for Diagnosis and Prognosis of High-grade Serous Ovarian Cancer
Genome and transcriptome sequence data from an ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) studyEGA dataset EGAD00001002556
Samples of primary tumors collected from 23 ovarian cancer patients 23 ovarian cancer patients were snap frozen in liquid nitrogen within one minute of surgical removal and transferred to the lab for
Genome and transcriptome sequence data from a metastatic ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) studyEGA dataset EGAD00001004930
To explore physician-reported knowledge, use, and perceptions of genetic testing for advanced ovarian cancer management. Gynecology/oncology specialists ( n = 390) in the US, Europe, Canada, Jap
Additional file 9: Table S7. Performance of the clinical data included in the exploratory analysis and their ability to classify patients into chemoresistant and chemosensitive groups.
